IGF1R and endometrial cancer: IGF1R showed decreased enrichment in the m6A antibody-bound fraction of the endometrial cancer when compared with adjacent normal endometrium (Figure 4B), thus indicating that m6A sites on IGF1R mRNAs disappeared in the endometrial cancer.